-

SHAREHOLDER ALERT: Robbins LLP Announces that AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of AdaptHealth Corp. (NASDAQ: AHCO) securities between November 11, 2019 and July 16, 2021, for violations of the Securities Exchange Act of 1934. AdaptHealth, with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the U.S.

If you suffered a loss due to AdaptHealth Corp.'s misconduct, click here.

AdaptHealth Corp. (AHCO) Made Misleading Statements Regarding its Business Prospects

According to the complaint, on July 8, 2019, DFB, a special purpose acquisition company, announced it had entered into a definitive merger agreement for a business combination with AdaptHealth, LLC. Upon the closing of the merger, DFB renamed itself AdaptHealth Corp. Between November 11, 2019 and July 16, 2021, AdaptHealth failed to disclose that it had misrepresented its organic growth trajectory by retroactively inflating past organic growth numbers without disclosing the changes, in violation of SEC regulations. As a result, the Company materially overstated its financial prospects.

On July 19, 2021, Jehoshaphat Research published a report alleging that AdaptHealth obscures its organic growth by "[r]etroactively changing past organic growth numbers to be higher, with no disclosure about the change." Jehoshaphat accused AdaptHealth of "experiencing double-digit organic decline" and "taking steps to obscure that decline which are expressly forbidden by the SEC." On this news, AdaptHealth's stock fell $1.51 per share, or almost 6%, to close at $23.96 per share on July 19, 2021.

If you purchased shares of AdaptHealth Corp. (AHCO) between November 11, 2019 and July 16, 2021, you have until September 27, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against AdaptHealth Corp. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:AHCO

Release Versions
$Cashtags

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges KD Stockholders to Contact the Firm for Information About the Class Action Against Kyndryl Holdings, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Kyndryl Holdings, Inc. (NYSE: KD) securities between August 7, 2024 and February 9, 2026. Kyndryl describes itself as a “technology services company, which engages in the provision of infrastructure services.” For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? Au...

Robbins LLP Reminds Inovio Pharmaceuticals, Inc. Stockholders of the Pending Class Action Against INO and Urges Harmed Stockholders to Seek More Information

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Robbins LLP Reminds ENPH Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Enphase Energy, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Enphase Energy, Inc. (NASDAQ: ENPH) securities between April 22, 2025 and October 28, 2025. Enphase is a global energy technology company focusing on solutions for solar generation, storage, and communication. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? Ap...
Back to Newsroom